Cite
Prevalence of mutations Methylentetrahydrofolate reductase (MTHFR), Prothrombin (II G20210G/G20210A) and Leyden V factor in patients undergoing studies by thrombophilic profile. Hospital San Vicente de Paul. Costa Rica, 2017 to 2018
MLA
Edgar Hernández Zúñiga, et al. “Prevalence of Mutations Methylentetrahydrofolate Reductase (MTHFR), Prothrombin (II G20210G/G20210A) and Leyden V Factor in Patients Undergoing Studies by Thrombophilic Profile. Hospital San Vicente de Paul. Costa Rica, 2017 to 2018.” Población y Salud En Mesoamérica, vol. 19, no. 2, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c61a743d5ab757956a7444b65ea1a5d9&authtype=sso&custid=ns315887.
APA
Edgar Hernández Zúñiga, Jonielle Garcia Quesada, & Melissa Granados Zamora. (2021). Prevalence of mutations Methylentetrahydrofolate reductase (MTHFR), Prothrombin (II G20210G/G20210A) and Leyden V factor in patients undergoing studies by thrombophilic profile. Hospital San Vicente de Paul. Costa Rica, 2017 to 2018. Población y Salud En Mesoamérica, 19(2).
Chicago
Edgar Hernández Zúñiga, Jonielle Garcia Quesada, and Melissa Granados Zamora. 2021. “Prevalence of Mutations Methylentetrahydrofolate Reductase (MTHFR), Prothrombin (II G20210G/G20210A) and Leyden V Factor in Patients Undergoing Studies by Thrombophilic Profile. Hospital San Vicente de Paul. Costa Rica, 2017 to 2018.” Población y Salud En Mesoamérica 19 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c61a743d5ab757956a7444b65ea1a5d9&authtype=sso&custid=ns315887.